Literature DB >> 18193233

Superior vena cava syndrome associated with Behcet's disease and 18 months' follow up: a case report.

Ilhan Sezer1, M Alkan Melikoglu, H Fatih Cay, Hilal Kocabaş, Bülent Bütün.   

Abstract

Behcet's disease is a multisystemic disorder that the main pathological defect is vasculitis and superior vena cava syndrome (SVCS) caused by vasculopathy is a rare manifestation of the disease. Although successful results of endovascular surgery were observed in some cases, medical therapy may have priority among the treatment alternatives because of the high risk of surgery due to the lesional localization of the vessel. In this report, a Behcet's disease case with SVCS and 18 months' follow-up data with medical therapy is presented.

Entities:  

Mesh:

Year:  2008        PMID: 18193233     DOI: 10.1007/s00296-008-0517-8

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  11 in total

1.  Behçet's syndrome: where do we stand?

Authors:  Hasan Yazici
Journal:  Am J Med       Date:  2002-01       Impact factor: 4.965

2.  Superior vena cava syndrome: a rare clinical manifestation of Behcet's disease.

Authors:  Ismail Hanta; Gamze Ucar; Sedat Kuleci; Süleyman Ozbek; Ali Kocabas
Journal:  Clin Rheumatol       Date:  2004-09-02       Impact factor: 2.980

Review 3.  New insights into the pathogenesis and therapy of Behçet's disease.

Authors:  Thurayya Arayssi; Ayad Hamdan
Journal:  Curr Opin Pharmacol       Date:  2004-04       Impact factor: 5.547

4.  Pulmonary artery aneurysms in Behçet syndrome.

Authors:  Vedat Hamuryudan; Tarik Er; Emire Seyahi; Canan Akman; Hasan Tüzün; Izzet Fresko; Sebahattin Yurdakul; Füruzan Numan; Hasan Yazici
Journal:  Am J Med       Date:  2004-12-01       Impact factor: 4.965

5.  Etiology and outcome of superior vena cava (SVC) obstruction in adults.

Authors:  Wipa Reechaipichitkul; Suchart Thongpaen
Journal:  Southeast Asian J Trop Med Public Health       Date:  2004-06       Impact factor: 0.267

6.  Promising new therapies for Behcet's disease.

Authors:  M H Houman; K Hamzaoui
Journal:  Eur J Intern Med       Date:  2006-05       Impact factor: 4.487

7.  Treatment of Behcet's syndrome.

Authors:  C G Barnes
Journal:  Rheumatology (Oxford)       Date:  2006-03       Impact factor: 7.580

8.  Endovascular treatment for superior vena cava obstruction in Behçet disease.

Authors:  Patrizio Castelli; Roberto Caronno; Gabriele Piffaretti; Matteo Tozzi; Chiara Lomazzi; Domenico Laganà; Gianpaolo Carrafiello; Salvatore Cuffari
Journal:  J Vasc Surg       Date:  2005-03       Impact factor: 4.268

9.  Vascular involvement in Behçet's disease: 8-year audit.

Authors:  M A Kuzu; C Ozaslan; C Köksoy; A Gürler; A Tüzüner
Journal:  World J Surg       Date:  1994 Nov-Dec       Impact factor: 3.352

10.  Endothelial cell activation and hypercoagulability in ocular Behçet's disease.

Authors:  Kiki Probst; Rob Fijnheer; Aniki Rothova
Journal:  Am J Ophthalmol       Date:  2004-05       Impact factor: 5.258

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.